全文获取类型
收费全文 | 6204篇 |
免费 | 561篇 |
国内免费 | 120篇 |
专业分类
耳鼻咽喉 | 71篇 |
儿科学 | 183篇 |
妇产科学 | 99篇 |
基础医学 | 800篇 |
口腔科学 | 102篇 |
临床医学 | 853篇 |
内科学 | 1263篇 |
皮肤病学 | 50篇 |
神经病学 | 649篇 |
特种医学 | 253篇 |
外科学 | 997篇 |
综合类 | 81篇 |
一般理论 | 3篇 |
预防医学 | 410篇 |
眼科学 | 191篇 |
药学 | 568篇 |
1篇 | |
中国医学 | 7篇 |
肿瘤学 | 304篇 |
出版年
2021年 | 99篇 |
2020年 | 55篇 |
2019年 | 90篇 |
2018年 | 91篇 |
2017年 | 88篇 |
2016年 | 80篇 |
2015年 | 86篇 |
2014年 | 139篇 |
2013年 | 206篇 |
2012年 | 269篇 |
2011年 | 274篇 |
2010年 | 154篇 |
2009年 | 186篇 |
2008年 | 228篇 |
2007年 | 286篇 |
2006年 | 275篇 |
2005年 | 256篇 |
2004年 | 195篇 |
2003年 | 182篇 |
2002年 | 170篇 |
2001年 | 170篇 |
2000年 | 191篇 |
1999年 | 140篇 |
1998年 | 84篇 |
1997年 | 70篇 |
1996年 | 72篇 |
1995年 | 65篇 |
1994年 | 68篇 |
1993年 | 65篇 |
1992年 | 171篇 |
1991年 | 144篇 |
1990年 | 174篇 |
1989年 | 155篇 |
1988年 | 158篇 |
1987年 | 147篇 |
1986年 | 132篇 |
1985年 | 132篇 |
1984年 | 104篇 |
1983年 | 90篇 |
1982年 | 64篇 |
1981年 | 62篇 |
1980年 | 61篇 |
1979年 | 87篇 |
1978年 | 87篇 |
1977年 | 84篇 |
1976年 | 67篇 |
1975年 | 58篇 |
1974年 | 82篇 |
1973年 | 79篇 |
1970年 | 55篇 |
排序方式: 共有6885条查询结果,搜索用时 56 毫秒
1.
Chopard Romain Campia Umberto Morin Lucas Jering Karola S. Almarzooq Zaid I. Snyder Julia Elizabeth Rizzo Samantha Waxman Aaron B. Goldhaber Samuel Z. Piazza Gregory 《Journal of thrombosis and thrombolysis》2022,54(3):449-460
Journal of Thrombosis and Thrombolysis - Multidisciplinary pulmonary embolism (PE) response teams have garnered widespread adoption given the complexities of managing acute PE and provide a... 相似文献
2.
Alexander D. Sherry MD Kelsey L. Corrigan MD MPH Ramez Kouzy MD Joseph Abi Jaoude MD Yumeng Yang MS Roshal R. Patel MD Douglas J. Totten MD MBA Neil B. Newman MD MS Prajnan Das MD MS MPH Cullen Taniguchi MD PhD Bruce Minsky MD Rebecca A. Snyder MD MPH C. David Fuller MD PhD Ethan Ludmir MD 《Cancer》2023,129(21):3430-3438
3.
Bergman David Modh Ankit Schultz Lonni Snyder James Mikkelsen Tom Shah Mira Ryu Samuel Siddiqui M. Salim Walbert Tobias 《Journal of neuro-oncology》2020,148(2):353-361
Journal of Neuro-Oncology - Outcomes for patients with recurrent high-grade glioma (HGG) progressing on bevacizumab (BEV) are dismal. Fractionated stereotactic radiosurgery (FSRS) has been shown to... 相似文献
4.
Daniel J. Snyder Thomas R. Kroshus Aakash Keswani Evan B. Garden Karl M. Koenig Kevin J. Bozic David S. Jevsevar Jashvant Poeran Calin S. Moucha 《The Journal of arthroplasty》2019,34(4):613-618
Background
Nursing Home Compare (NHC) ratings, created and maintained by Medicare, are used by both hospitals and consumers to aid in the skilled nursing facility (SNF) selection process. To date, no studies have linked NHC ratings to actual episode-based outcomes. The purpose of this study was to evaluate whether NHC ratings are valid predictors of 90-day complications, readmission, and bundle costs for patients discharged to an SNF after primary total joint arthroplasty (TJA).Methods
All SNF-discharged primary TJA cases in 2017 at a multihospital academic health system were queried. Demographic, psychosocial, and clinical variables were manually extracted from the health record. Medicare NHC ratings were then collected for each SNF. For patients in the Medicare bundle, postacute and total bundle cost was extracted from claims.Results
Four hundred eighty-eight patients were discharged to a total of 105 unique SNFs. In multivariate analysis, overall NHC rating was not predictive of 90-day readmission/major complications, >75th percentile postacute cost, or 90-day bundle cost exceeding the target price. SNF health inspection and quality measure ratings were also not predictive of 90-day readmission/major complications or bundle performance. A higher SNF staffing rating was independently associated with a decreased odds for >75th percentile 90-day postacute spend (odds ratio, 0.58; P = .01) and a 90-day bundle cost exceeding the target price (odds ratio = 0.69; P = .02) but was similarly not predictive of 90-day readmission/complications.Conclusion
Results of our study suggest that Medicare's NHC tool is not a useful predictor of 90-day costs, complications, or readmissions for SNFs within our health system. 相似文献5.
Illicit substance use, especially of inhalants, is a public health crisis during adolescence, particularly for maltreated youths. This study advances the literature by highlighting the prevalence of inhalant use among child welfare–involved adolescents. Using the National Survey of Child and Adolescent Well-Being (NSCAW) II data set, case-status factors, problem behaviors, deviant peers, delinquency, depression, and school peer engagement were inspected using logistic regression. Females, delinquency, deviant peers, problematic behaviors, and depression are positively related to inhalant use, whereas youth school peer engagement mitigates inhalant use. Attention to peer relationships and psychosocial risk factors is necessary for adolescents. 相似文献
6.
7.
John G. Baust Kristi K. Snyder Kimberly L. Santucci Anthony T. Robilotto Robert G. Van Buskirk John M. Baust 《International journal of hyperthermia》2019,36(2):10-16
AbstractCryoablation (CA) is unique as the singular energy deprivation therapy that impacts all cellular processes. CA is independent of cell cycle stage and degree of cellular stemness. Importantly, CA is typically applied as a non-repetitive (single session) treatment that does not support adaptative mutagenesis as do many repetitive therapies. CA is characterized by the launch of multiple forms of cell death including (a) ice-related physical damage, (b) initiation of cellular stress responses (kill switch activation) and launch of necrosis and apoptosis, (c) vascular stasis, and (d) likely activation of ablative immune responses. CA is not without limitation related to the thermal gradient formed between cryoprobe surface (~?185°C) and the distal surface of the freeze zone (~0°C) requiring freeze margin extension beyond the tumor boundary (up to ~1?cm). This limitation is mitigated in part by commonly applied dual freeze thaw cycles and the use of freeze sensitizing adjuvants. This review will (1) identify the cascade of damaging effects of the freeze–thaw process, its physical and molecular-based relationships, (2) a likely immunological involvement (abscopic effect), and (3) explore the use of freeze-sensitizing adjuvants necessary to limit freezing beyond the tumor margin. 相似文献
8.
ABSTRACTMultiplicity issues can be multidimensional: A confirmatory clinical trial may be designed to have efficacy assessed with two or more primary endpoints, for multiple dose groups, and at several post-baseline visits. Controlling for multiplicity in this situation is challenging because there can be a hierarchy with respect to some but not all measurements. If the higher dose is considered more efficacious, multiplicity approach may evaluate the higher dose with higher priority through a fixed sequential testing framework for dose assessments in combination with a Hochberg approach for endpoints. The lower dose is only assessed when the higher dose has significant results, which reduces the power for detecting signals in the lower dose group. However, in some instances the higher dose may associate with tolerability or safety concerns that preclude regulatory approval. A real confirmatory clinical trial with such challenges is provided as an illustrative example. We discuss closed testing procedures based on multi-way averages of comparisons for this complex multiplicity situation through illustrative case analyses and a simulation study. Such strategies manage the higher dose and the lower dose with equal priority, and they enable evaluation of the multiple endpoints at multiple visits collectively with power being reasonably high. 相似文献
9.
Alice C. Chang Jutieh Lincoln Wendy M. Lantaff Stephanie A. Gernant Heather A. Jaynes William Doucette Margie E. Snyder 《Journal of the American Pharmacists Association》2018,58(1):61-66.e7
Objectives
To characterize actions performed by pharmacists and support staff during provision of medication therapy management (MTM) and to compare actions performed according to practice characteristics.Methods
A purposeful sample of 7 MTM practices (2 call centers and 5 community practices) was identified and visited by investigators. Pharmacists and support staff were observed during their routine provision of MTM. Investigators characterized “major” (e.g., preparation for a comprehensive medication review) and “minor” (i.e., specific steps in overarching major action) actions with the use of a time-and-motion approach.Results
A total of 32 major and 469 minor actions were observed. Practices were characterized as Later Maturity Level or Early Maturity Level on the basis of their self-reported MTM appointment volume, self-assessment of the extent of integration of chronic care model principles, and payer mix. Later Maturity Level practices were more likely to deliver follow-up medication therapy reviews and comprehensive medication reviews (CMRs) as opposed to targeted medication reviews (TMRs) and to receive physician referrals for MTM. Later Maturity Level practices were also more likely to use paid interns than pharmacy rotation students. CMR activities observed at Later Maturity Level practices lasted a median of 30.8 minutes versus 20.3 minutes for CMR activities at Early Maturity Level practices. Similarly, TMR activities observed at Later Maturity Level practices were longer: a median of 31.0 minutes versus 12.3 minutes. At Later Maturity Level practices, pharmacists spent a greater proportion of time providing patient education, while support staff spent a greater proportion of time on tasks such as capturing demographics and introducing or explaining MTM.Conclusion
MTM activities were longer at Later Maturity Level practices, and these practices were more likely to use paid pharmacy interns and to receive physician referrals for MTM. This work provides a foundation for future research. 相似文献10.
Jihye Park Brenna E. Blackburn Kerry Rowe John Snyder Yuan Wan Vikrant Deshmukh Michael Newman Alison Fraser Ken Smith Kim Herget Lindsay Burt Theresa Werner David K. Gaffney Ana Maria Lopez Kathi Mooney Mia Hashibe 《Annals of epidemiology》2018,28(6):377-384